Thursday

23rd Sep 2021

MEPs back higher medical safety standards following PIP scandal

Medical devices ranging from pacemakers to breast implants will be subject to stricter controls under rules agreed by MEPs on Tuesday (22 October).

Deputies voted by a large majority to support two new laws covering more than 10,000 medical devices currently sold in Europe. But more ambitious plans to beef up the EU's medicines agency were shelved in a last-minute change of heart by conservative members.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

  • MEPs have agreed on stricter rules for medical devices (Photo: surroundsound500)

Under the reforms, patients would be registered and given an ‘implant card’ with detailed information on the medical device with which they were about to get fitted. Rules on granting safety-approval to devices would be delegated to in-house 'experts', with particular attention on 'high risk' devices such as heart valves.

Meanwhile, the draft directive would also allow regulators to carry out unannounced inspections of factories making medical products.

Deputies are also keen to ensure that 'over the counter' HIV tests should only be bought in pharmacies with a prescription. The General rule should be 'prescription-only' but member states would be able to have special exemptions.

Speaking after the vote, Peter Liese, a German centre-right MEP, and one of two deputies responsible for preparing parliament's report, said that MEPs had secured "a great result for patients" which industry could "live with."

But Liese's enthusiasm was not shared by centre-left deputy Dagmar Roth-Behrendt, who complained that her centre-right EPP colleagues had reneged on an agreement that would have required the European Medicines Agency to authorise 'high risk' devices before they were allowed to go on sale.

Instead, deputies voted to allow EMA to set up special expert groups of doctors and specialists to scrutinise new technologies and devices, but the recommendations would not be legally binding.

Roth-Behrendt said that she "would have expected a better result and described the EPP's stance as "totally ridiculous and unjustifiable", adding that her proposal had been supported by doctors and patient groups.

Lawmakers had demanded reforms to the EU's six year old directive on medical devices in the wake of the breast implant scandal involving the now defunct French-firm Poly Implant Prothese (PIP) in 2011.

PIP had been caught using industrial grade silicone to replace the gel in implants, affecting thousands of women, many of which are still to be compensated.

For their part, consumer groups offered qualified support for the result.

“Today’s vote finally enhances both consumers’ information and involvement in the monitoring of such devices," said Monique Goyens, of pan-European consumer group (BEUC), who added that the proposed regime would make it easier for patients to report faulty devices.

However she added that "consumers will continue to be used as guinea pigs."

MEPs now face a race against time to secure agreement on the legislation with governments.

Although the commission tabled the proposal over a year ago, ministers are yet to agree their position on the file.

Feature

Medical technology: Advancing too fast for its own good?

The rapid advancement of medical technology has contributed to people living longer, healthier lives but consumer and campaign groups say devices should come under more scrutiny before they are used on patients.

Negotiations set for new, tougher, EU ethics body

Last week, a majority in the European Parliament voted in favour of creating a new EU ethics body, covering MEPs and the European Commission. German Green MEP Daniel Freund, who spearheaded the report, says negotiations are likely to start soon.

News in Brief

  1. French ambassador to return to US after Macron-Biden call
  2. Borrell: EU needs armed force independent of US
  3. Polish region does U-turn on gay rights
  4. Johnson makes fun of French anger on submarine deal
  5. Ukraine vows 'tough response' after gun attack on top aide
  6. Poland again delays ruling on primacy of EU law
  7. EU to table emergency proposals on gas-price surge
  8. EU delays first set of anti-greenwashing rules

Investigation

EU negotiators defend high Covid vaccines prices paid to pharma

In September 2020, the EU Commission's top vaccine negotiator made a pledge - doses would cost between €5 and €15, Sandra Gallina assured MEPs. Little did she know that her fixed cap would crumble under pressure from jabmakers.

Opinion

The EU's 'backyard' is not in the Indo-Pacific

Europe is no longer an Indo-Pacific power. It will not become an Indo-Pacific power. And if it keeps overreaching its geopolitical ambitions, Europe might lose its credibility as a power - entirely.

Stakeholders' Highlights

  1. Nordic Council of MinistersNATO Secretary General guest at the Session of the Nordic Council
  2. Nordic Council of MinistersCan you love whoever you want in care homes?
  3. Nordic Council of MinistersNineteen demands by Nordic young people to save biodiversity
  4. Nordic Council of MinistersSustainable public procurement is an effective way to achieve global goals
  5. Nordic Council of MinistersNordic Council enters into formal relations with European Parliament
  6. Nordic Council of MinistersWomen more active in violent extremist circles than first assumed

Latest News

  1. More French names linked to Russia election-monitoring
  2. Negotiations set for new, tougher, EU ethics body
  3. Lead energy MEP silent on gas meetings before vote
  4. WHO makes major cut in 'safe' air-pollution levels
  5. EU negotiators defend high Covid vaccines prices paid to pharma
  6. The EU's 'backyard' is not in the Indo-Pacific
  7. French MEPs lead bogus EU monitoring of Russia vote
  8. Europeans think new 'Cold War' is here - but not for them

Join EUobserver

Support quality EU news

Join us